ListenFuture-Listening for Their Future: Deaf and Hard-of-Hearing Adolescents (ListenFuture)

February 24, 2026 updated by: Heikki Löppönen

ListenFuture-Listening for Their Future: The Complex Associations Between Hearing, Cognition, Spoken Language, Literacy and Psychosocial Wellbeing in Deaf and Hard-of-Hearing Adolescents

ListenFuture, a nation-wide multidisciplinary project, brings new knowledge on complex associations between listening, cognition, language, literacy, and psychosocial wellbeing in deaf and hard-of-hearing (DHH) adolescents. Earlier findings indicate that DHH adolescents remain at a risk to achieving age-appropriate skills. The associations among these skills can also be language-dependent. The investigators use behavioral methods and questionnaires. The investigators study speech perception in noise, listening, and listening-related fatigue to reveal how DHH adolescents cope in today's noisy environment. The investigators study cognitive skills and executive functions, spoken language and literacy skills to find out the current state-of-knowledge. The investigators study psychosocial wellbeing, school burnout and factors associated with them. The investigators will utilize supervised and interpretable machine learning to analyse the performance domains that could best predict the outcomes of DHH adolescents. The investigators expect our project to have broad societal impact for DHH adolescents, healthcare, school, and other stakeholders.

Study Overview

Status

Recruiting

Detailed Description

ListenFuture provides comprehensive insights into challenges deaf and hard-of-hearing (DHH) adolescents face in speech perception, language, and literacy, skills essential for use, creation, and integration of information. The investigators will explore the following skills and their complex associations: 1) auditory speech perception, 2) cognitive skills and executive functions, 3) spoken language, 4) literacy, and 5) psychosocial wellbeing and school burnout. The investigators will analyse the demographic, cognitive, speech perception and language processing domains that best predict the outcomes. ListenFuture has the potential to enhance the wellbeing and participation of DHH adolescents and provide valuable information for intervention services and policy making.

Study Type

Observational

Enrollment (Estimated)

256

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Helsinki, Finland, 00029
        • Recruiting
        • Helsinki University Hospital
        • Contact:
      • Kuopio, Finland, 70029
        • Recruiting
        • Kuopio University Hospital / University of Eastern Finland
        • Contact:
      • Oulu, Finland, 90220
        • Recruiting
        • Oulu University Hospital
        • Contact:
      • Oulu, Finland, 90014
        • Recruiting
        • University of Oulu
        • Contact:
      • Tampere, Finland, 33101
        • Recruiting
        • Tampere University Hospital
        • Contact:
      • Turku, Finland, 20521
        • Recruiting
        • Turku University Hospital
        • Contact:
      • Turku, Finland, 20700
        • Recruiting
        • Åbo Academy University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Children with hearing loss are voluntary participants who are in care at the university hospitals in Finland.

Children with typical hearing are voluntary participants from the cities of Finland.

Description

Inclusion Criteria:

  1. Group 1

    - Bilateral mild to complete hearing loss

  2. Group 2:

    • Typical hearing (PTA<20dB)
    • Typical cognitive, linguistic and literacy development

Exclusion Criteria:

Group 1 and Group 2:

  • heart conditions
  • developmental brain disorders
  • chromosome anomalies
  • severe inner ear anomalies
  • impairments in both distance senses hearing and vision

Group 2:

- concerns regarding attention and psychosocial wellbeing

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
children with hearing loss
children with mild-complete hearing loss
children with typical hearing
normal hearing

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical Evaluation of Language Fundamentals (CELF5)
Time Frame: Day 1
General language skills. Measurement of language performance against age-matched peers
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of reading, writing and arithmetic skills (LUKILASSE)
Time Frame: Day 1
Assessment of school skills in relation to the goals required by the grade level (in Finnish language)
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

December 31, 2031

Study Registration Dates

First Submitted

February 10, 2026

First Submitted That Met QC Criteria

February 10, 2026

First Posted (Actual)

February 18, 2026

Study Record Updates

Last Update Posted (Actual)

February 25, 2026

Last Update Submitted That Met QC Criteria

February 24, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

anonymized and published outcome data can be shared with other researchers when the research completed

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hearing Disorders and Deafness

Subscribe